Adequacy of Hemodialysis Serves as an Independent Predictor of Humoral Response to ChAdOx1 Prime-Boost Vaccination in Hemodialysis Patients

Background: Immune response assessed by the quantification of neutralizing antibodies (nAbs) and predictors associated with immunogenicity after the prime-boost ChAdOx1 (Oxford–AstraZeneca) COVID-19 vaccine in hemodialysis (HD) patients remains unclear. Methods: This prospective study enrolled 174 H...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chun-Yu, Liu, Kuan-Ting, Shih, Shin-Ru, Ye, Jung-Jr, Chen, Yih-Ting, Hsu, Cheng-Kai, Pan, Heng-Chih, Hsu, Heng-Jung, Sun, Chiao-Yin, Lee, Chin-Chan, Wu, Chun-Ying, Lai, Chi-Chun, Wu, I-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229890/
https://www.ncbi.nlm.nih.gov/pubmed/35746621
http://dx.doi.org/10.3390/v14061149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229890/
https://www.ncbi.nlm.nih.gov/pubmed/35746621
http://dx.doi.org/10.3390/v14061149

Ejemplares similares